IceCure Medical
ICCM
9 hedge funds and large institutions have $172K invested in IceCure Medical in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.07% less ownership
Funds ownership: 0.08% → 0.01% (-0.07%)
31% less funds holding
Funds holding: 13 → 9 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less capital invested
Capital invested by funds: $54.8M → $172K (-$54.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$37.2K |
| 2 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$6.98K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.95K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$853 |
| 5 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
+$620 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$52.5M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.4M |
| 3 |
Jane Street
New York
|
-$249K |
| 4 |
JP Morgan Chase
New York
|
-$247K |
| 5 |
Goldman Sachs
New York
|
-$165K |
ICCM Hedge Fund Activity: Q1 2022 in Review
9 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2022, worth a combined $172K — down 100% from $54.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ICCM and 4 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $37.2K. The largest seller was Credit Suisse, exiting entirely with an estimated $52.5M sold.
- 9 institutional investors held IceCure Medical (ICCM) as of Q1 2022, down from 13 in Q4 2021.
- Funds reported $172K of IceCure Medical stock for Q1 2022, down 100% quarter-over-quarter.
- 4 funds opened new IceCure Medical positions in Q1 2022 and 8 closed out, a net change of -4 holders.
- The largest IceCure Medical buyer in Q1 2022 was Citadel Advisors, an estimated $37.2K added.
- The largest IceCure Medical seller in Q1 2022 was Credit Suisse, an estimated $52.5M sold.
Based on aggregated 13F filings for Q1 2022.